HapticV1, PascalFrancis, Curation, bibRecord, 000054

Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia

Identifieur interne : 000054 ( PascalFrancis/Curation ); précédent : 000053; suivant : 000055

Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia

Auteurs : S. E. Purdon [Canada] ; P. Flor-Henry [Canada]

Source :

Schizophrenia research [ 0920-9964 ] ; 2000.

RBID : Pascal:00-0466810

Descripteurs français

Pascal (Inist)
- Schizophrénie, Etude expérimentale, Acuité, Olfaction, Perception, Spécialisation hémisphérique, Latéralité, Asymétrie, Etude comparative, Traitement, Chimiothérapie, Neuroleptique, Psychotrope, Encéphale, Système nerveux central, Exploration clinique, Etude longitudinale, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Acuity, Asymmetry, Brain (vertebrata), Central nervous system, Chemotherapy, Clinical investigation, Comparative study, Experimental study, Follow up study, Hemispheric specialization, Human, Laterality, Neuroleptic, Olfaction, Perception, Psychotropic, Schizophrenia, Treatment.

Abstract

Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment I was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8 weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.

A01	`01`	`1`		`@0 0920-9964`
A03		`1`		`@0 Schizophr. res.`
A05				`@2 44`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia`
A11	`01`	`1`		`@1 PURDON (S. E.)`
A11	`02`	`1`		`@1 FLOR-HENRY (P.)`
A14	`01`			`@1 Alberta Hospital Edmonton, Box 307 @2 Edmonton, Alberta, T5J 2J7 @3 CAN @Z 1 aut. @Z 2 aut.`
A20				`@1 221-232`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 21734 @5 354000091905140070`
A44				`@0 0000 @1 © 2000 INIST-CNRS. All rights reserved.`
A45				`@0 2 p.1/4`
A47	`01`	`1`		`@0 00-0466810`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Schizophrenia research`
A66	`01`			`@0 NLD`
C01	`01`		`ENG`	@0 Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment I was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8 weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.
C02	`01`	`X`		`@0 002B18C06A`
C02	`02`	`X`		`@0 002B02B03`
C03	`01`	`X`	`FRE`	`@0 Schizophrénie @5 01`
C03	`01`	`X`	`ENG`	`@0 Schizophrenia @5 01`
C03	`01`	`X`	`SPA`	`@0 Esquizofrenia @5 01`
C03	`02`	`X`	`FRE`	`@0 Etude expérimentale @5 02`
C03	`02`	`X`	`ENG`	`@0 Experimental study @5 02`
C03	`02`	`X`	`SPA`	`@0 Estudio experimental @5 02`
C03	`03`	`X`	`FRE`	`@0 Acuité @5 03`
C03	`03`	`X`	`ENG`	`@0 Acuity @5 03`
C03	`03`	`X`	`SPA`	`@0 Agudeza @5 03`
C03	`04`	`X`	`FRE`	`@0 Olfaction @5 04`
C03	`04`	`X`	`ENG`	`@0 Olfaction @5 04`
C03	`04`	`X`	`SPA`	`@0 Olfación @5 04`
C03	`05`	`X`	`FRE`	`@0 Perception @5 05`
C03	`05`	`X`	`ENG`	`@0 Perception @5 05`
C03	`05`	`X`	`SPA`	`@0 Percepción @5 05`
C03	`06`	`X`	`FRE`	`@0 Spécialisation hémisphérique @5 06`
C03	`06`	`X`	`ENG`	`@0 Hemispheric specialization @5 06`
C03	`06`	`X`	`SPA`	`@0 Especialización hemisférica @5 06`
C03	`07`	`X`	`FRE`	`@0 Latéralité @5 07`
C03	`07`	`X`	`ENG`	`@0 Laterality @5 07`
C03	`07`	`X`	`SPA`	`@0 Lateralidad @5 07`
C03	`08`	`X`	`FRE`	`@0 Asymétrie @5 08`
C03	`08`	`X`	`ENG`	`@0 Asymmetry @5 08`
C03	`08`	`X`	`SPA`	`@0 Asimetría @5 08`
C03	`09`	`X`	`FRE`	`@0 Etude comparative @5 09`
C03	`09`	`X`	`ENG`	`@0 Comparative study @5 09`
C03	`09`	`X`	`SPA`	`@0 Estudio comparativo @5 09`
C03	`10`	`X`	`FRE`	`@0 Traitement @5 10`
C03	`10`	`X`	`ENG`	`@0 Treatment @5 10`
C03	`10`	`X`	`SPA`	`@0 Tratamiento @5 10`
C03	`11`	`X`	`FRE`	`@0 Chimiothérapie @5 11`
C03	`11`	`X`	`ENG`	`@0 Chemotherapy @5 11`
C03	`11`	`X`	`SPA`	`@0 Quimioterapia @5 11`
C03	`12`	`X`	`FRE`	`@0 Neuroleptique @5 12`
C03	`12`	`X`	`ENG`	`@0 Neuroleptic @5 12`
C03	`12`	`X`	`SPA`	`@0 Neuroléptico @5 12`
C03	`13`	`X`	`FRE`	`@0 Psychotrope @2 FX @5 13`
C03	`13`	`X`	`ENG`	`@0 Psychotropic @2 FX @5 13`
C03	`13`	`X`	`SPA`	`@0 Psicotropo @2 FX @5 13`
C03	`14`	`X`	`FRE`	`@0 Encéphale @5 17`
C03	`14`	`X`	`ENG`	`@0 Brain (vertebrata) @5 17`
C03	`14`	`X`	`SPA`	`@0 Encéfalo @5 17`
C03	`15`	`X`	`FRE`	`@0 Système nerveux central @5 18`
C03	`15`	`X`	`ENG`	`@0 Central nervous system @5 18`
C03	`15`	`X`	`SPA`	`@0 Sistema nervioso central @5 18`
C03	`16`	`X`	`FRE`	`@0 Exploration clinique @5 19`
C03	`16`	`X`	`ENG`	`@0 Clinical investigation @5 19`
C03	`16`	`X`	`SPA`	`@0 Exploración clínica @5 19`
C03	`17`	`X`	`FRE`	`@0 Etude longitudinale @5 20`
C03	`17`	`X`	`ENG`	`@0 Follow up study @5 20`
C03	`17`	`X`	`SPA`	`@0 Estudio longitudinal @5 20`
C03	`18`	`X`	`FRE`	`@0 Homme @5 21`
C03	`18`	`X`	`ENG`	`@0 Human @5 21`
C03	`18`	`X`	`SPA`	`@0 Hombre @5 21`
C07	`01`	`X`	`FRE`	`@0 Psychose @5 37`
C07	`01`	`X`	`ENG`	`@0 Psychosis @5 37`
C07	`01`	`X`	`SPA`	`@0 Psicosis @5 37`
N21				`@1 311`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001459

Links to Exploration step

Pascal:00-0466810

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title>
<author><name sortKey="Purdon, S E" sort="Purdon, S E" uniqKey="Purdon S" first="S. E." last="Purdon">S. E. Purdon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Alberta Hospital Edmonton, Box 307</s1>
<s2>Edmonton, Alberta, T5J 2J7</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Flor Henry, P" sort="Flor Henry, P" uniqKey="Flor Henry P" first="P." last="Flor-Henry">P. Flor-Henry</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Alberta Hospital Edmonton, Box 307</s1>
<s2>Edmonton, Alberta, T5J 2J7</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0466810</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0466810 INIST</idno>
<idno type="RBID">Pascal:00-0466810</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001459</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000054</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title>
<author><name sortKey="Purdon, S E" sort="Purdon, S E" uniqKey="Purdon S" first="S. E." last="Purdon">S. E. Purdon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Alberta Hospital Edmonton, Box 307</s1>
<s2>Edmonton, Alberta, T5J 2J7</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Flor Henry, P" sort="Flor Henry, P" uniqKey="Flor Henry P" first="P." last="Flor-Henry">P. Flor-Henry</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Alberta Hospital Edmonton, Box 307</s1>
<s2>Edmonton, Alberta, T5J 2J7</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Schizophrenia research</title>
<title level="j" type="abbreviated">Schizophr. res.</title>
<idno type="ISSN">0920-9964</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Schizophrenia research</title>
<title level="j" type="abbreviated">Schizophr. res.</title>
<idno type="ISSN">0920-9964</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acuity</term>
<term>Asymmetry</term>
<term>Brain (vertebrata)</term>
<term>Central nervous system</term>
<term>Chemotherapy</term>
<term>Clinical investigation</term>
<term>Comparative study</term>
<term>Experimental study</term>
<term>Follow up study</term>
<term>Hemispheric specialization</term>
<term>Human</term>
<term>Laterality</term>
<term>Neuroleptic</term>
<term>Olfaction</term>
<term>Perception</term>
<term>Psychotropic</term>
<term>Schizophrenia</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Schizophrénie</term>
<term>Etude expérimentale</term>
<term>Acuité</term>
<term>Olfaction</term>
<term>Perception</term>
<term>Spécialisation hémisphérique</term>
<term>Latéralité</term>
<term>Asymétrie</term>
<term>Etude comparative</term>
<term>Traitement</term>
<term>Chimiothérapie</term>
<term>Neuroleptique</term>
<term>Psychotrope</term>
<term>Encéphale</term>
<term>Système nerveux central</term>
<term>Exploration clinique</term>
<term>Etude longitudinale</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment I was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8 weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0920-9964</s0>
</fA01>
<fA03 i2="1"><s0>Schizophr. res.</s0>
</fA03>
<fA05><s2>44</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>PURDON (S. E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FLOR-HENRY (P.)</s1>
</fA11>
<fA14 i1="01"><s1>Alberta Hospital Edmonton, Box 307</s1>
<s2>Edmonton, Alberta, T5J 2J7</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>221-232</s1>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21734</s2>
<s5>354000091905140070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>2 p.1/4</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0466810</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Schizophrenia research</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment I was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8 weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B18C06A</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B02B03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Schizophrénie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Schizophrenia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Esquizofrenia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Etude expérimentale</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Experimental study</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Estudio experimental</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Acuité</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Acuity</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Agudeza</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Olfaction</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Olfaction</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Olfación</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Perception</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Perception</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Percepción</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Spécialisation hémisphérique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Hemispheric specialization</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Especialización hemisférica</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Latéralité</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Laterality</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Lateralidad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Asymétrie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Asymmetry</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Asimetría</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Traitement</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Treatment</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Neuroleptique</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Neuroleptic</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Neuroléptico</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Psychotrope</s0>
<s2>FX</s2>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Psychotropic</s0>
<s2>FX</s2>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Psicotropo</s0>
<s2>FX</s2>
<s5>13</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Encéphale</s0>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Brain (vertebrata)</s0>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Encéfalo</s0>
<s5>17</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>18</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Exploration clinique</s0>
<s5>19</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Clinical investigation</s0>
<s5>19</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Exploración clínica</s0>
<s5>19</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE"><s0>Etude longitudinale</s0>
<s5>20</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG"><s0>Follow up study</s0>
<s5>20</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA"><s0>Estudio longitudinal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE"><s0>Homme</s0>
<s5>21</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG"><s0>Human</s0>
<s5>21</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA"><s0>Hombre</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Psychose</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Psychosis</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Psicosis</s0>
<s5>37</s5>
</fC07>
<fN21><s1>311</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000054 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000054 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    HapticV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:00-0466810
   |texte=   Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
}}

This area was generated with Dilib version V0.6.23.
Data generation: Mon Jun 13 01:09:46 2016. Site generation: Wed Mar 6 09:54:07 2024

	Serveur d'exploration sur les dispositifs haptiques
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les dispositifs haptiques

Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia

Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri